OBJECTIVES: To determine viral and immune factors involved in transmission and control of HIV-1 infection in persons without functional CCR5. DESIGN: Understanding transmission and control of HIV-1 in persons homozygous for CCR5(Δ32) is important given efforts to develop HIV-1 curative therapies aimed at modifying or disrupting CCR5 expression. METHODS: We identified two HIV-infected CCR5(Δ32/Δ32) individuals among a cohort of patients with spontaneous control of HIV-1 infection without antiretroviral therapy and determined coreceptor usage of the infecting viruses. We assessed genetic evolution of full-length HIV-1 envelope sequences by single-genome analysis from one participant and his sexual partner, and explored HIV-1 immune responses and HIV-1 mutations following virologic escape and disease progression. RESULTS: Both participants experienced viremia of less than 4000 RNA copies/ml with preserved CD4(+) T-cell counts off antiretroviral therapy for at least 3.3 and 4.6 years after diagnosis, respectively. One participant had phenotypic evidence of X4 virus, had no known favorable human leukocyte antigen alleles, and appeared to be infected by minority X4 virus from a pool that predominately used CCR5 for entry. The second participant had virus that was unable to use CXCR4 for entry in phenotypic assay but was able to engage alternative viral coreceptors (e.g., CXCR6) in vitro. CONCLUSION: Our study demonstrates that individuals may be infected by minority X4 viruses from a population that predominately uses CCR5 for entry, and that viruses may bypass traditional HIV-1 coreceptors (CCR5 and CXCR4) completely by engaging alternative coreceptors to establish and propagate HIV-1 infection.
OBJECTIVES: To determine viral and immune factors involved in transmission and control of HIV-1 infection in persons without functional CCR5. DESIGN: Understanding transmission and control of HIV-1 in persons homozygous for CCR5(Δ32) is important given efforts to develop HIV-1 curative therapies aimed at modifying or disrupting CCR5 expression. METHODS: We identified two HIV-infectedCCR5(Δ32/Δ32) individuals among a cohort of patients with spontaneous control of HIV-1 infection without antiretroviral therapy and determined coreceptor usage of the infecting viruses. We assessed genetic evolution of full-length HIV-1 envelope sequences by single-genome analysis from one participant and his sexual partner, and explored HIV-1 immune responses and HIV-1 mutations following virologic escape and disease progression. RESULTS: Both participants experienced viremia of less than 4000 RNA copies/ml with preserved CD4(+) T-cell counts off antiretroviral therapy for at least 3.3 and 4.6 years after diagnosis, respectively. One participant had phenotypic evidence of X4 virus, had no known favorable human leukocyte antigen alleles, and appeared to be infected by minority X4 virus from a pool that predominately used CCR5 for entry. The second participant had virus that was unable to use CXCR4 for entry in phenotypic assay but was able to engage alternative viral coreceptors (e.g., CXCR6) in vitro. CONCLUSION: Our study demonstrates that individuals may be infected by minority X4 viruses from a population that predominately uses CCR5 for entry, and that viruses may bypass traditional HIV-1 coreceptors (CCR5 and CXCR4) completely by engaging alternative coreceptors to establish and propagate HIV-1 infection.
Authors: C Balotta; P Bagnarelli; M Violin; A L Ridolfo; D Zhou; A Berlusconi; S Corvasce; M Corbellino; M Clementi; M Clerici; M Moroni; M Galli Journal: AIDS Date: 1997-08 Impact factor: 4.177
Authors: M W Smith; M Dean; M Carrington; C Winkler; G A Huttley; D A Lomb; J J Goedert; T R O'Brien; L P Jacobson; R Kaslow; S Buchbinder; E Vittinghoff; D Vlahov; K Hoots; M W Hilgartner; S J O'Brien Journal: Science Date: 1997-08-15 Impact factor: 47.728
Authors: J Rucker; A L Edinger; M Sharron; M Samson; B Lee; J F Berson; Y Yi; B Margulies; R G Collman; B J Doranz; M Parmentier; R W Doms Journal: J Virol Date: 1997-12 Impact factor: 5.103
Authors: Coral-Ann M Almeida; Corine Bronke; Steven G Roberts; Elizabeth McKinnon; Niamh M Keane; Abha Chopra; Carl Kadie; Jonathan Carlson; David W Haas; Sharon A Riddler; Richard Haubrich; David Heckerman; Simon Mallal; Mina John Journal: J Immunol Date: 2011-08-05 Impact factor: 5.422
Authors: S L M Teixeira; N B R de Sá; D P Campos; A B Coelho; M L Guimarães; T C N F Leite; V G Veloso; M G Morgado Journal: Genes Immun Date: 2014-04-10 Impact factor: 2.676
Authors: Jonathan Z Li; Zabrina L Brumme; Chanson J Brumme; Hongying Wang; John Spritzler; Michael N Robertson; Michael M Lederman; Mary Carrington; Bruce D Walker; Robert T Schooley; Daniel R Kuritzkes Journal: J Infect Dis Date: 2011-04-01 Impact factor: 5.226
Authors: Pablo Tebas; David Stein; Winson W Tang; Ian Frank; Shelley Q Wang; Gary Lee; S Kaye Spratt; Richard T Surosky; Martin A Giedlin; Geoff Nichol; Michael C Holmes; Philip D Gregory; Dale G Ando; Michael Kalos; Ronald G Collman; Gwendolyn Binder-Scholl; Gabriela Plesa; Wei-Ting Hwang; Bruce L Levine; Carl H June Journal: N Engl J Med Date: 2014-03-06 Impact factor: 91.245
Authors: Dongzhu Ma; Cuiling Xu; Anthony R Cillo; Benjamin Policicchio; Jan Kristoff; George Haret-Richter; John W Mellors; Ivona Pandrea; Cristian Apetrei Journal: J Virol Date: 2015-04-01 Impact factor: 5.103
Authors: Karine Dubé; David Evans; Lynda Dee; Laurie Sylla; Jeff Taylor; Asheley Skinner; Bryan J Weiner; Sandra B Greene; Stuart Rennie; Joseph D Tucker Journal: AIDS Res Hum Retroviruses Date: 2017-07-10 Impact factor: 2.205
Authors: Kersten K Koelsch; Thomas A Rasmussen; William J Hey-Nguyen; Chester Pearson; Yin Xu; Michelle Bailey; Katherine H Marks; Sarah C Sasson; Mark S Taylor; Robyn Tantau; Solange Obeid; Brad Milner; Orla Morrissey; Angie N Pinto; Kazuo Suzuki; Michael P Busch; Sheila M Keating; Philipp Kaiser; Steven Yukl; Joseph K Wong; Bonnie M Hiener; Sarah Palmer; John Zaunders; Jeffrey J Post; Derek J Chan; Sharon Avery; Sam T Milliken; Anthony D Kelleher; Sharon R Lewin; David A Cooper Journal: J Acquir Immune Defic Syndr Date: 2017-07-01 Impact factor: 3.731
Authors: Anh Q Le; Jeremy Taylor; Winnie Dong; Rosemary McCloskey; Conan Woods; Ryan Danroth; Kanna Hayashi; M-J Milloy; Art F Y Poon; Zabrina L Brumme Journal: Sci Rep Date: 2015-12-03 Impact factor: 4.379
Authors: Michael M Lederman; Paula M Cannon; Judith S Currier; Carl H June; Hans Peter Kiem; Daniel R Kuritzkes; Sharon R Lewin; David M Margolis; Joseph M McCune; John W Mellors; Timothy W Schacker; Rafick P Sekaly; Pablo Tebas; Bruce D Walker; Daniel C Douek Journal: Pathog Immun Date: 2016
Authors: Timothy J Henrich; Hiroyu Hatano; Oliver Bacon; Louise E Hogan; Rachel Rutishauser; Alison Hill; Mary F Kearney; Elizabeth M Anderson; Susan P Buchbinder; Stephanie E Cohen; Mohamed Abdel-Mohsen; Christopher W Pohlmeyer; Remi Fromentin; Rebecca Hoh; Albert Y Liu; Joseph M McCune; Jonathan Spindler; Kelly Metcalf-Pate; Kristen S Hobbs; Cassandra Thanh; Erica A Gibson; Daniel R Kuritzkes; Robert F Siliciano; Richard W Price; Douglas D Richman; Nicolas Chomont; Janet D Siliciano; John W Mellors; Steven A Yukl; Joel N Blankson; Teri Liegler; Steven G Deeks Journal: PLoS Med Date: 2017-11-07 Impact factor: 11.069